These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29237376)

  • 1. The Role of PET in Monitoring Therapy in Fungal Infections.
    Ankrah AO; Klein HC; Span LFR; de Vries EFJ; Dierckx RAJO; Sathekge MM; Glaudemans AWJM
    Curr Pharm Des; 2018; 24(7):795-805. PubMed ID: 29237376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections.
    Ankrah AO; Span LFR; Klein HC; de Jong PA; Dierckx RAJO; Kwee TC; Sathekge MM; Glaudemans AWJM
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):174-183. PubMed ID: 30343434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections.
    Hot A; Maunoury C; Poiree S; Lanternier F; Viard JP; Loulergue P; Coignard H; Bougnoux ME; Suarez F; Rubio MT; Mahlaoui N; Dupont B; Lecuit M; Faraggi M; Lortholary O
    Clin Microbiol Infect; 2011 Mar; 17(3):409-17. PubMed ID: 20636432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging.
    Douglas AP; Thursky KA; Worth LJ; Drummond E; Hogg A; Hicks RJ; Slavin MA
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):166-173. PubMed ID: 29882160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of invasive fungal infections: a role for polyenes.
    Chandrasekar P
    J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current challenges in the management of invasive fungal infections.
    Lai CC; Tan CK; Huang YT; Shao PL; Hsueh PR
    J Infect Chemother; 2008 Apr; 14(2):77-85. PubMed ID: 18622668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging moulds: epidemiological trends and antifungal resistance.
    Miceli MH; Lee SA
    Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
    Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
    Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007).
    Raghuram A; Restrepo A; Safadjou S; Cooley J; Orloff M; Hardy D; Butler S; Koval CE
    Liver Transpl; 2012 Sep; 18(9):1100-9. PubMed ID: 22577087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.
    Anesi JA; Baddley JW
    Infect Dis Clin North Am; 2016 Mar; 30(1):277-96. PubMed ID: 26739603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive fungal infections in liver transplantation.
    Liu X; Ling Z; Li L; Ruan B
    Int J Infect Dis; 2011 May; 15(5):e298-304. PubMed ID: 21345708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive mold infections: recent advances in management approaches.
    Chandrasekar P
    Leuk Lymphoma; 2009 May; 50(5):703-15. PubMed ID: 19337880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances and challenges in the treatment of invasive fungal infections.
    Shao PL; Huang LM; Hsueh PR
    Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of invasive fungal infections.
    Tuite NL; Lacey K
    Methods Mol Biol; 2013; 968():1-23. PubMed ID: 23296882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive mycoses: diagnostic challenges.
    Ostrosky-Zeichner L
    Am J Med; 2012 Jan; 125(1 Suppl):S14-24. PubMed ID: 22196205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012.
    Azie N; Neofytos D; Pfaller M; Meier-Kriesche HU; Quan SP; Horn D
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):293-300. PubMed ID: 22789847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive fungal infection--laboratory diagnosis and antifungal treatment.
    Shao PL; Huang LM; Hsueh PR
    J Microbiol Immunol Infect; 2006 Jun; 39(3):178-88. PubMed ID: 16783447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing strategies for the management of invasive fungal infections.
    Rapp RP
    Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current challenges in the diagnosis and management of invasive fungal infections: report from the 15th International Symposium on Infections in the Immunocompromised Host: Thessaloniki, Greece, 22-25 June 2008.
    Groll AH; McNeil Grist L
    Int J Antimicrob Agents; 2009 Feb; 33(2):101-4. PubMed ID: 19008080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in antifungal therapy.
    Sable CA; Strohmaier KM; Chodakewitz JA
    Annu Rev Med; 2008; 59():361-79. PubMed ID: 17967129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.